Search Results - "Leclerc, Marjorie"

Experiences of patients with poststroke spasticity throughout a botulinum toxin treatment cycle: Results from a prospective ethnographic study by Jacinto, Jorge, Lysandropoulos, Andreas, Leclerc, Marjorie, Calvi-Gries, Françoise

“…This study was conducted to capture the experience of patients with poststroke spasticity (PSS) throughout one botulinum neurotoxin A (BoNT-A) treatment cycle…”
Get full text

Similarities and Differences in the Perception of Atopic Dermatitis Burden Between Patients, Caregivers, and Independent Physicians (AD-GAP Survey) by Paller, Amy S., Weidinger, Stephan, Capozza, Korey, Pink, Andrew E., Tang, Mark, Guillaume, Xavier, Praestgaard, Amy, Leclerc, Marjorie, Chuang, Chien-Chia, Thomas, Ryan B., Prescilla, Randy

“…Introduction Atopic dermatitis (AD)—a chronic inflammatory skin disease characterized by intense itching—can have a detrimental impact on quality of life…”
Get full text

The Healthcare Professionals’ Perspective on Impact and Actions Taken Following Severe Infusion Reaction Events in Oncology Centers in Europe by Kafatos, George, Dube, Sabada, Burdon, Peter, Lowe, Kimberly, Leclerc, Marjorie, Flinois, Alain, Demonty, Gaston

“…Purpose The study aim was to describe the management strategies used for severe infusion-related reactions (SIRs) and understand the impact of such events in…”
Get full text

16367 The burden of combined facial and truncal acne by Tan, Jerry, Chavda, Rajeev, Leclerc, Marjorie, York, J.P., Dréno, Brigitte

Get full text

Management of EGFR Inhibitor-induced Skin Toxicity and Factors Impacting Patients’ Adherence to Skin Toxicity Treatment: Health Care Provider and Patient Surveys in European Oncology Centers by Kafatos, George, Dube, Sabada, Burdon, Peter, Demonty, Gaston, Flinois, Alain, Leclerc, Marjorie, Lowe, Kimberly, Feudjo-Tepie, Maurille, Segaert, Siegfried

“…This study aimed to provide a description of existing measures for the prevention and management of epidermal growth factor receptor inhibitor monoclonal…”
Get full text

Description of Feelings, Perception, and Experience Before and After Switching from IV Daratumumab to the SC Form: A Mixed-Method, Cross-Sectional Survey in Multiple Myeloma Patients in Europe by Magarotto, Valeria, Thevenon, Julien, Morgan, Kate, Ten Seldam, Silene, Iraqi, Wafae, Guillaume, Xavier, Leclerc, Marjorie, Graziani-Taugeron, Claire, Rault, Bleuenn, Horchi, Dahbia

“…To provide real-world data on patient perceptions and experiences with subcutaneous (SC) versus intravenous (IV) daratumumab. This was a cross-sectional,…”
Get full text